Literature DB >> 16234449

The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.

F Koc1, S Kavuncu, T Kansu, G Acaroglu, E Firat.   

Abstract

AIMS: To evaluate the sensitivity and specificity of 0.5% apraclonidine test in the diagnosis of oculosympathetic paresis (OSP).
METHOD: Apraclonidine (0.5%) was administered to 31 eyes, nine with a diagnosis of Horner syndrome (HS), 22 with bilateral OSP caused by diabetes, and to 54 control eyes. All were confirmed with the cocaine test. The effects on pupil diameter and upper eyelid level were observed 1 hour later.
RESULTS: Apraclonidine caused a mean dilation of 2.04 mm (range 1--4.5) (p<0.001) in the pupils with OSP and it caused pupillary constriction in the control eyes with a mean change of -0.14 mm (range 0.5 to --1) (p<0.05). It caused reversal of anisocoria in all HS cases. Its effects on both pupil diameters and upper lid levels differed significantly between the groups (p<0.001). The mean elevation in the upper lid was 1.75 mm (range 1--4) in the OSP group (p<0.001) and 0.61 mm (range 0--3) in the control group (p<0.001).
CONCLUSION: The effect of the apraclonidine (0.5%) test on the pupil diameter was diagnostic for OSP and had at least the same sensitivity and specificity as the cocaine test for the diagnosis of OSP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16234449      PMCID: PMC1772929          DOI: 10.1136/bjo.2005.074492

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients.

Authors:  Darron A Bacal; Susan R Levy
Journal:  Arch Ophthalmol       Date:  2004-02

2.  Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine.

Authors:  I P Pollack; R H Brown; A S Crandall; A L Robin; R H Stewart; G L White
Journal:  Arch Ophthalmol       Date:  1988-06

3.  Horner's syndrome. Ocular supersensitivity to adrenergic amines.

Authors:  M E Langham; G W Weinstein
Journal:  Arch Ophthalmol       Date:  1967-10

4.  Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty.

Authors:  A L Robin; I P Pollack; B House; C Enger
Journal:  Arch Ophthalmol       Date:  1987-05

5.  Apraclonidine. A one-week dose-response study.

Authors:  H D Jampel; A L Robin; H A Quigley; I P Pollack
Journal:  Arch Ophthalmol       Date:  1988-08

6.  The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers.

Authors:  D A Abrams; A L Robin; I P Pollack; J M deFaller; L DeSantis
Journal:  Arch Ophthalmol       Date:  1987-09

7.  Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy.

Authors:  A L Robin; I P Pollack; J M deFaller
Journal:  Arch Ophthalmol       Date:  1987-09

Review 8.  Review: alpha 2 and DA2 agonists as antiglaucoma agents: comparative pharmacology and clinical potential.

Authors:  D E Potter; C E Crosson; A R Heath; M J Ogidigben
Journal:  J Ocul Pharmacol       Date:  1990

9.  Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors.

Authors:  C E Crosson; A R Heath; G W DeVries; D E Potter
Journal:  Curr Eye Res       Date:  1992-10       Impact factor: 2.424

10.  Short-term effects of unilateral 1% apraclonidine therapy.

Authors:  A L Robin
Journal:  Arch Ophthalmol       Date:  1988-07
View more
  18 in total

1.  Impact of T3 thoracoscopic sympathectomy on pupillary function: a cause of partial Horner's syndrome?

Authors:  Ricard Ramos; Anna Ureña; Francisco Rivas; Ivan Macia; Gabriela Rosado; Sandra Pequeño; Cristina Masuet; Maria Badia; Maribel Miguel; Miguel-Angel Delgado; Ignacio Escobar; Juan Moya
Journal:  Surg Endosc       Date:  2011-11-02       Impact factor: 4.584

Review 2.  Current pharmacologic testing for Horner syndrome.

Authors:  Mansoor Mughal; Reid Longmuir
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

Review 3.  A review of Horner's syndrome in small animals.

Authors:  Danielle M Zwueste; Bruce H Grahn
Journal:  Can Vet J       Date:  2019-01       Impact factor: 1.008

Review 4.  Adult Horner's syndrome: a combined clinical, pharmacological, and imaging algorithm.

Authors:  I Davagnanam; C L Fraser; K Miszkiel; C S Daniel; G T Plant
Journal:  Eye (Lond)       Date:  2013-02-01       Impact factor: 3.775

5.  Horner Syndrome in a Case of Neuromyelitis Optica.

Authors:  Lilia Lovera; Walter M Jay; Jose Biller
Journal:  Neuroophthalmology       Date:  2014-02-07

6.  14th EUNOS Congress: PORTO, PORTUGAL, 16-19 JUNE 2019.

Authors: 
Journal:  Neuroophthalmology       Date:  2019-06-07

Review 7.  Clinical Evaluation of Blepharoptosis: Distinguishing Age-Related Ptosis from Masquerade Conditions.

Authors:  Michelle W Latting; Alison B Huggins; Douglas P Marx; Joseph N Giacometti
Journal:  Semin Plast Surg       Date:  2017-02       Impact factor: 2.314

8.  Apraclonidine and my pupil.

Authors:  Melissa Cambron; Heidi Maertens; Luc Crevits
Journal:  Clin Auton Res       Date:  2011-03-08       Impact factor: 4.435

Review 9.  Horner's syndrome, Pseudo-Horner's syndrome, and simple anisocoria.

Authors:  Timothy J Martin
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

10.  Lower lid entropion secondary to treatment with alpha-1a receptor antagonist: a case report.

Authors:  Salman Waqar; Peter Simcock
Journal:  J Med Case Rep       Date:  2010-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.